⌘K

Login Start Free

Home/Filings/4/0001415889-24-026766

4//SEC Filing

Farnum Rhonda 4

Accession 0001415889-24-026766

CIK 0001583107other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 8:42 PM ET

Size

4.7 KB

Accession

0001415889-24-026766

Insider Transaction Report

Form 4

Period: 2024-11-11

Theravance Biopharma, Inc.TBPH

SVP, COMM & MEDICAL AFFAIRS

Transactions

Sale
Ordinary Shares
2024-11-11$9.00/sh−4,000$36,000→ 322,743 total

Documents

1 file

4
form4-11142024_011103.xmlPrimary

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1

filerCIK 0001898490

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 8:42 PM ET
Size: 4.7 KB

View on SEC.gov